98 related articles for article (PubMed ID: 791317)
1. Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.
Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
Br J Clin Pharmacol; 1975 Feb; 2(1):37-9. PubMed ID: 791317
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.
Boullin DJ; Woods HF; Grimes RP; Grahame-Smith DG
Br J Clin Pharmacol; 1975 Feb; 2(1):29-35. PubMed ID: 791316
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
Oppenheim B; Hefez A; Youdim MB
Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.
Boullin DJ; Grimes RP
Br J Clin Pharmacol; 1976 Aug; 3(4):649-53. PubMed ID: 22216508
[TBL] [Abstract][Full Text] [Related]
5. Increases in aggregation by and uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine.
Baldacci M; Baldacci M; Bergel TD; Born GV; Hickman M
Br J Pharmacol; 1980 May; 69(1):113-8. PubMed ID: 7378650
[TBL] [Abstract][Full Text] [Related]
6. Human platelet function as a model for investigating the clinical efficacy of chlorpromazine.
Youdim MB; Hefez A; Oppenheim B
Br J Clin Pharmacol; 1981 Oct; 12(4):535-42. PubMed ID: 7295487
[TBL] [Abstract][Full Text] [Related]
7. Effects of chlorpromazine on serotonin uptake in blood platelets.
Arora RC; Meltzer HY
Psychiatry Res; 1983 May; 9(1):23-8. PubMed ID: 6577481
[TBL] [Abstract][Full Text] [Related]
8. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.
Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
Br J Pharmacol; 1975 Jan; 53(1):121-5. PubMed ID: 1125484
[TBL] [Abstract][Full Text] [Related]
10. Platelet function after the administration of chlorpromazine to human subjects.
Warlow C; Ogston D; Douglas AS
Haemostasis; 1976; 5(1):21-6. PubMed ID: 1269995
[TBL] [Abstract][Full Text] [Related]
11. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
[TBL] [Abstract][Full Text] [Related]
12. [Comparative effect of chlorpromazine, imipramine and papaverine on the blood platelet function].
Bartel' V; Gluza E; Markvardt F
Farmakol Toksikol; 1976; 39(3):296-301. PubMed ID: 193725
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
Glusa E; Markwardt F
Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
[TBL] [Abstract][Full Text] [Related]
14. Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects.
Hilton BP
J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):711-4. PubMed ID: 4844137
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aggregation of rabbit and human platelets induced by adrenaline and 5-hydroxytryptamine by KB-R7943, a Na(+)/Ca(2+) exchange inhibitor.
Takano S; Kimura J; Ono T
Br J Pharmacol; 2001 Apr; 132(7):1383-8. PubMed ID: 11264230
[TBL] [Abstract][Full Text] [Related]
16. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
Boullin DJ; Glenton PA
Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
18. The effect of 5-hydroxytryptamine and epinephrine on newborn platelets.
Alebouyeh M; Lusher JM; Ameri MR; Evans RK; Robinson A
Eur J Pediatr; 1978 Jul; 128(3):163-8. PubMed ID: 668724
[TBL] [Abstract][Full Text] [Related]
19. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
Bailey SR; Andrews MJ; Elliott J; Cunningham F
Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
[TBL] [Abstract][Full Text] [Related]
20. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]